Albers Jeffrey W. (CIK 1638474) reported 21 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-08-10). Recent activity: Buy SYRE (5,000 shares), Sell SYRE (5,000 shares), Sell SYRE (8,000 shares), Sell SYRE (10,000 shares), Buy KYMR (5,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | Spyre Therapeutics, Inc. (SYRE) | Director | Buy | 5,000 | $51,950 |
| 2026-08-10 | Spyre Therapeutics, Inc. (SYRE) | Director | Sell | 5,000 | $522,350 |
| 2026-08-10 | Spyre Therapeutics, Inc. (SYRE) | Director | Sell | 8,000 | $835,040 |
| 2026-08-10 | Spyre Therapeutics, Inc. (SYRE) | Director | Sell | 10,000 | $1.0M |
| 2025-12-08 | Kymera Therapeutics, Inc. (KYMR) | Director | Buy | 5,000 | $70,900 |
| 2025-12-08 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 2,748 | $245,451 |
| 2025-12-08 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 2,252 | $203,356 |
| 2025-10-14 | Kymera Therapeutics, Inc. (KYMR) | Director | Buy | 5,000 | $51,700 |
| 2025-10-14 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 5,000 | $295,950 |
| 2025-07-21 | Blueprint Medicines Corp (BPMC) | Director | Sell | 5,777 | $0 |
| 2025-07-21 | Blueprint Medicines Corp (BPMC) | Director | Sell | 144,755 | $0 |
| 2025-06-24 | Blueprint Medicines Corp (BPMC) | Director | Buy | 3,902 | $499,924 |
| 2025-06-03 | Kymera Therapeutics, Inc. (KYMR) | Director | Buy | 6,349 | $65,649 |
| 2025-06-03 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 6,349 | $311,101 |
| 2025-05-29 | Blueprint Medicines Corp (BPMC) | Director | Buy | 5,000 | $180,250 |
| 2025-05-29 | Blueprint Medicines Corp (BPMC) | Director | Sell | 4,350 | $439,437 |
| 2025-05-29 | Blueprint Medicines Corp (BPMC) | Director | Sell | 650 | $66,254 |
| 2025-03-17 | Blueprint Medicines Corp (BPMC) | Director | Sell | 5,766 | $512,021 |
| 2025-03-14 | Blueprint Medicines Corp (BPMC) | Director | Buy | 7,500 | $270,375 |
| 2025-03-14 | Blueprint Medicines Corp (BPMC) | Director | Sell | 5,700 | $499,434 |
| 2025-03-14 | Blueprint Medicines Corp (BPMC) | Director | Sell | 1,800 | $159,066 |
Source: SEC Form 4 filings · as of 2026-08-10